FATE THERAPEUTICS RECEIVES REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FROM FDA FOR FT819 TO TREAT MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Reuters · 6d ago

Please log in to view news